 Oct. 29, 2020 | Today's news and insights for medtech leaders The renal care business continues to grow during the pandemic but lower ER utilization and fewer hospitalizations, particularly in the U.S., hurt revenues by more than $65 million in the quarter. |
The medtech predicts the trauma surgery and emergency medicine-focused products will begin adding up to $70 million in revenue next year, providing growth drivers outside its key interventional urology segment. |
While Needham analysts contend one action removes an overhang for Inogen, Invacare and ResMed, those at Jefferies see a "major negative" in the agency's determination to lower rates outlined in a proposed rule. |
Practical guide – pipetting guidelines to ensure compliance with GLP and GMP.
| The medtech is moving deeper into the extremity orthopaedics turf fought over by the likes of Zimmer Biomet and Stryker acquisition target Wright Medical. | Featured Resources FROM: Boston Micro Fabrication | Mold-free, ultra-high resolution micro 3D printing | | From Our Library Webinar - on demand By studioID |
Webinar - on demand By studioID |
View all resources What We're Reading  MassDevice |
 STAT |
 Cybersecurity Dive |
 The Wall Street Journal |
 MedCity News | Dive Into a Topic | 
0 Comments